Zeo ScientifiX, Inc.
ZEOXdata completeness 100%15 fiscal years on fileZeo ScientifiX, Inc. earns about -471% on equity, and has bought back 99% of its shares over 5 years. The cash-flow models don't apply cleanly here — the ledger says why below.Whether it’s worth owning at today’s price is the last question — and yours to answer, below.
| Figure | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|
| Revenue | $5.6M1 | $6.49M2 | $4.56M3 | $4.62M4 | $5.2M4 |
| Net income | −$12.8M5 | −$8.9M6 | −$6.99M7 | −$4.71M8 | −$5.52M8 |
| Operating cash flow | −$2.68M9 | −$3.17M10 | −$2.2M11 | −$1.45M12 | −$718,00012 |
| Capital expenditure | $424,74213 | $824,74314 | $26,00015 | — | $23,00016 |
| Free cash flow (derived) | −$3.11M9 | −$3.99M10 | −$2.22M11 | — | −$741,00012 |
| Total debt | $140,43417 | $563,11118 | $657,00019 | $680,00020 | $243,00020 |
| Cash & equivalents | $108,57021 | $3.75M22 | $1.76M23 | $657,00023 | $221,00023 |
| Diluted shares | 1.13B | 5.7M | 7.0M | 6.3M | 6.4M |
Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).
10 shares is a claim on −$2.22 of net worth that earned you −$8.61 and generated −$1.16 of cash last year, against $0.38 of debt.
It earned an average -471% on equity over 5 years. Compare that to what it costs to fund the business.
seeing a moat in the numbers →Share count is down 99% over 5 years — management has been buying back stock, quietly handing owners a bigger slice. Total debt has risen 73% over the same window.
reading capital allocation →Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.
Different models answer different questions — which to trust when →
- 10-K · period ending 2021-10-31 · accession 0001829126-23-001524 (Revenues)
- 10-K · period ending 2022-10-31 · accession 0001829126-24-000541 (Revenues)
- 10-K · period ending 2023-10-31 · accession 0001829126-25-000536 (Revenues)
- 10-K · period ending 2024-10-31 · accession 0001829126-26-000763 (Revenues)
- 10-K · period ending 2021-10-31 · accession 0001829126-23-001524 (NetIncomeLoss)
- 10-K · period ending 2022-10-31 · accession 0001829126-24-000541 (NetIncomeLoss)
- 10-K · period ending 2023-10-31 · accession 0001829126-25-000536 (NetIncomeLoss)
- 10-K · period ending 2024-10-31 · accession 0001829126-26-000763 (NetIncomeLoss)
- 10-K · period ending 2021-10-31 · accession 0001829126-23-001524 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2022-10-31 · accession 0001829126-24-000541 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2023-10-31 · accession 0001829126-25-000536 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2024-10-31 · accession 0001829126-26-000763 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2021-10-31 · accession 0001829126-23-001524 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2022-10-31 · accession 0001829126-24-000541 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2023-10-31 · accession 0001829126-25-000536 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2025-10-31 · accession 0001829126-26-000763 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2021-10-31 · accession 0001829126-22-003605 (DebtCurrent)
- 10-K · period ending 2022-10-31 · accession 0001829126-24-000541 (LongTermDebtCurrent)
- 10-K · period ending 2023-10-31 · accession 0001829126-25-000536 (LongTermDebtCurrent)
- 10-K · period ending 2024-10-31 · accession 0001829126-26-000763 (LongTermDebtCurrent)
- 10-K · period ending 2021-10-31 · accession 0001829126-22-003605 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2022-10-31 · accession 0001829126-25-000536 (CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents)
- 10-K · period ending 2023-10-31 · accession 0001829126-26-000763 (CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents)